Skip to main navigation Skip to search Skip to main content

LANZHOU UNIVERSITY TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED's US Patent application for "GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF" is in published phase now

Press/Media

Period10 Apr 2023

Media coverage

1

Media coverage

  • TitleLANZHOU UNIVERSITY TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED's US Patent application for "GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF" is in published phase now
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date10/04/23
    PersonsHUANXIANG LIU
View all 1
View less